scholarly journals Oral health in children with cerebral palsy: A pediatric neurologist’s perspective

2020 ◽  
Vol 10 ◽  
pp. 8
Author(s):  
Aman Preet Singh Sohal

Cerebral palsy, one of the most common causes of physical disability in children, is a group of complex neurological disorders caused by non-progressive injury to the developing brain which leads to abnormalities of movement and posture. Dental surgeons must be aware of common practical neurological problems encountered by these children on a day-to-day basis. Awareness of the various factors and strategies mentioned in the article will not only have a major impact on the child’s oral health but also on the quality of life of these children and their families.

2013 ◽  
Vol 34 (2) ◽  
pp. 56-63 ◽  
Author(s):  
Jenny Abanto ◽  
Adriana Oliveira Ortega ◽  
Daniela Prócida Raggio ◽  
Marcelo Bönecker ◽  
Fausto Medeiros Mendes ◽  
...  

2016 ◽  
Vol 40 (5) ◽  
pp. 375-387 ◽  
Author(s):  
Eman A El Ashiry ◽  
Sumer M Alaki ◽  
Sumaya M Nouri

Objective: To assess the parents' perception of the oral health-related quality of life (OHRQOL) in children with Cerebral Palsy (CP) and compare it with normally developing children. Study Design: 63 children with CP were recruited from 8 disability centers, and 99 healthy controls were recruited from 5 elementary schools. The ages of the children in both groups were from 6-12 years. The Franciscan Hospital for Children Oral Health-Related Quality of Life (FHC-OHRQOL) was used to measure the OHRQOL and an oral examination was conducted in the schools/centers of the children to assess the teeth, gingival health, and oral hygiene. Results: The FHC-OHRQOL showed a significant difference in 3 out of 4 sections indicating lower OHRQOL in the CP group. The examination showed no significant difference in the dental and gingival health and in the level of oral hygiene. Conclusion: The OHRQOL of children with CP is significantly lower than that of normally developing children although the oral health status of children with CP is not significantly different from that of normally developing children.


2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Jenny Abanto ◽  
Thiago S Carvalho ◽  
Marcelo Bönecker ◽  
Adriana OL Ortega ◽  
Ana L Ciamponi ◽  
...  

2021 ◽  
Author(s):  
Alanoud Akram Aman ◽  
Bashaer Baharoon ◽  
Haifa Jamal Idrees ◽  
Ahad Mohammedyusuf Taj ◽  
Bassmah Ali Alzahrani ◽  
...  

2008 ◽  
Vol 50 (3) ◽  
pp. 199-203 ◽  
Author(s):  
A Shelly ◽  
E Davis ◽  
E Waters ◽  
A Mackinnon ◽  
D Reddihough ◽  
...  

Toxins ◽  
2022 ◽  
Vol 14 (1) ◽  
pp. 43
Author(s):  
Christian Wong ◽  
Ian Westphall ◽  
Josephine Sandahl Michelsen

Sixty-seven percent of children with cerebral palsy (CCP) experience pain. Pain is closely interrelated to diminished quality of life. Despite this, pain is an overlooked and undertreated clinical problem. The objective of this study was to examine the analgesic effect of a single lower extremity intramuscular injection of Abobotulinum toxin A/Dysport in CCP. Twenty-five CCP with at least moderate pain (r-FLACC ≥ 4) during passive range of motion were included. Localized pain and pain in everyday living were measured by r-FLACC and the Paediatric Pain Profile (PPP), respectively. Functional improvements were evaluated by the goal attainment scale (SMART GAS). Quality of life was evaluated by either the CPCHILD or the CP-QOL. The subjects were evaluated at baseline before injection, then after 4, 12, and 28 weeks. Twenty-two subjects had a significant mean and maximum localized pain reduction (p < 0.001) at four weeks post-treatment in 96% (21/22). The reduction was maintained at 12 (19/19) and 28 weeks (12/15). Daily pain evaluated by the PPP was significantly reduced and functional SMART GAS goals were significantly achieved from 4 to 28 weeks. Quality of life improved significantly at four weeks (CPCHILD). Significant functional gains and localized and daily pain reduction were seen from 4 to 28 weeks.


Sign in / Sign up

Export Citation Format

Share Document